Literature DB >> 23071307

Saving lives by training innate immunity with bacille Calmette-Guerin vaccine.

Peter Aaby1, Christine Stabell Benn.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23071307      PMCID： PMC3491466          DOI： 10.1073/pnas.1215761109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  18 in total

1.  The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial.

Authors:  Nicole Ritz; Binita Dutta; Susan Donath; Dan Casalaz; Tom G Connell; Marc Tebruegge; Roy Robins-Browne; Willem A Hanekom; Warwick J Britton; Nigel Curtis
Journal:  Am J Respir Crit Care Med       Date:  2011-11-03       Impact factor: 21.405

Review 2.  Vaccination strategies to reduce the risk of leukaemia and melanoma.

Authors:  John M Grange; John L Stanford; Cynthia A Stanford; Klaus F Kölmel
Journal:  J R Soc Med       Date:  2003-08       Impact factor: 5.344

3.  Non-specific effects of BCG?

Authors:  Paul E M Fine; Peter G Smith; Stephen J W Evans
Journal:  J Infect Dis       Date:  2011-12-06       Impact factor: 5.226

4.  Tuberculin reaction, BCG scar, and lower female mortality.

Authors:  Adam Roth; Morten Sodemann; Henrik Jensen; Anja Poulsen; Per Gustafson; Christian Weise; Justino Gomes; Queba Djana; Marianne Jakobsen; May-Lill Garly; Amabelia Rodrigues; Peter Aaby
Journal:  Epidemiology       Date:  2006-09       Impact factor: 4.822

5.  Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes.

Authors:  Johanneke Kleinnijenhuis; Jessica Quintin; Frank Preijers; Leo A B Joosten; Daniela C Ifrim; Sadia Saeed; Cor Jacobs; Joke van Loenhout; Dirk de Jong; Hendrik G Stunnenberg; Ramnik J Xavier; Jos W M van der Meer; Reinout van Crevel; Mihai G Netea
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

6.  Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guérin vaccination at first health center contact.

Authors:  Sofie Biering-Sørensen; Peter Aaby; Bitiguida Mutna Napirna; Adam Roth; Henrik Ravn; Amabelia Rodrigues; Hilton Whittle; Christine Stabell Benn
Journal:  Pediatr Infect Dis J       Date:  2012-03       Impact factor: 2.129

7.  Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial.

Authors:  Peter Aaby; Cesário L Martins; May-Lill Garly; Carlito Balé; Andreas Andersen; Amabelia Rodrigues; Henrik Ravn; Ida M Lisse; Christine S Benn; Hilton C Whittle
Journal:  BMJ       Date:  2010-11-30

Review 8.  No one is naive: the significance of heterologous T-cell immunity.

Authors:  Raymond M Welsh; Liisa K Selin
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

9.  Risk of lymphoma and leukaemia after bacille Calmette-Guérin and smallpox vaccination: a Danish case-cohort study.

Authors:  Marie Villumsen; Signe Sørup; Tine Jess; Henrik Ravn; Thomas Relander; Jennifer L Baker; Christine Stabell Benn; Thorkild I A Sørensen; Peter Aaby; Adam Roth
Journal:  Vaccine       Date:  2009-09-09       Impact factor: 3.641

10.  Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries.

Authors:  Peter Aaby; Christine Benn; Jens Nielsen; Ida Maria Lisse; Amabelia Rodrigues; Henrik Ravn
Journal:  BMJ Open       Date:  2012-05-22       Impact factor: 2.692
View more
  18 in total

Review 1.  Adaptation in the innate immune system and heterologous innate immunity.

Authors:  Stefan F Martin
Journal:  Cell Mol Life Sci       Date:  2014-07-06       Impact factor: 9.261

2.  Mycobacteria Manipulate G-Protein-Coupled Receptors to Increase Mucosal Rac1 Expression in the Lungs.

Authors:  Nader Alaridah; Nataliya Lutay; Erik Tenland; Anna Rönnholm; Oskar Hallgren; Manoj Puthia; Gunilla Westergren-Thorsson; Gabriela Godaly
Journal:  J Innate Immun       Date:  2016-12-24       Impact factor: 7.349

3.  Ready to benefit from training: heterologous effects of early life immunization.

Authors:  Orly Levy; Ofer Levy
Journal:  Trans R Soc Trop Med Hyg       Date:  2015-01       Impact factor: 2.184

4.  Neonatal BCG vaccination is associated with enhanced T-helper 1 immune responses to heterologous infant vaccines.

Authors:  Daniel H Libraty; Lei Zhang; Marcia Woda; Luz P Acosta; Anamae Obcena; Job D Brion; Rosario Z Capeding
Journal:  Trials Vaccinol       Date:  2014

5.  Innate Immune Responses after Airway Epithelial Stimulation with Mycobacterium bovis Bacille-Calmette Guérin.

Authors:  Erik Tenland; Gisela Håkansson; Nader Alaridah; Nataliya Lutay; Anna Rönnholm; Oskar Hallgren; Gunilla Westergren-Thorsson; Gabriela Godaly
Journal:  PLoS One       Date:  2016-10-10       Impact factor: 3.240

6.  Characterizing the BCG Induced Macrophage and Neutrophil Mechanisms for Defense Against Mycobacterium tuberculosis.

Authors:  Thomas E Bickett; Jennifer McLean; Elizabeth Creissen; Linda Izzo; Cassidy Hagan; Antonio J Izzo; Fabiola Silva Angulo; Angelo A Izzo
Journal:  Front Immunol       Date:  2020-06-18       Impact factor: 7.561

Review 7.  Proposing BCG Vaccination for Mycobacterium avium ss. paratuberculosis (MAP) Associated Autoimmune Diseases.

Authors:  Coad Thomas Dow
Journal:  Microorganisms       Date:  2020-02-05

Review 8.  Translation of peptidoglycan metabolites into immunotherapeutics.

Authors:  Matthew E Griffin; Charles W Hespen; Yen-Chih Wang; Howard C Hang
Journal:  Clin Transl Immunology       Date:  2019-11-29

9.  Increased Lytic Efficiency of Bovine Macrophages Trained with Killed Mycobacteria.

Authors:  Ramon A Juste; Marta Alonso-Hearn; Joseba M Garrido; Naiara Abendaño; Iker A Sevilla; Christian Gortazar; José de la Fuente; Lucas Dominguez
Journal:  PLoS One       Date:  2016-11-07       Impact factor: 3.240

10.  BCG vaccination at birth and early childhood hospitalisation: a randomised clinical multicentre trial.

Authors:  Lone Graff Stensballe; Signe Sørup; Peter Aaby; Christine Stabell Benn; Gorm Greisen; Dorthe Lisbeth Jeppesen; Nina Marie Birk; Jesper Kjærgaard; Thomas Nørrelykke Nissen; Gitte Thybo Pihl; Lisbeth Marianne Thøstesen; Poul-Erik Kofoed; Ole Pryds; Henrik Ravn
Journal:  Arch Dis Child       Date:  2016-07-21       Impact factor: 3.791
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.